These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy. Bombardieri E; Crippa F; Cataldo I; Chiti A; Seregni E; Soresi E; Boffi R; Invernizzi G; Buraggi GL Eur J Cancer; 1995; 31A(2):184-8. PubMed ID: 7718323 [TBL] [Abstract][Full Text] [Related]
3. 111In-octreotide scintigraphy in small cell lung cancer. Semprebene A; Ferraironi A; Franciotti G; Venturo I; Giunta S; Lopez M; Maini CL Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764 [TBL] [Abstract][Full Text] [Related]
4. [The scintigraphy of somatostatin receptors in the carcinoid tumor]. Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324 [TBL] [Abstract][Full Text] [Related]
5. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer. Vaccarili M; Lococo A; Fabiani F; Staffilano A Tumori; 2000; 86(3):224-8. PubMed ID: 10939603 [TBL] [Abstract][Full Text] [Related]
7. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer. Soresi E; Bombardieri E; Chiti A; Boffi R; Invernizzi G; Crippa F; Maffioli L Tumori; 1995; 81(2):125-7. PubMed ID: 7778214 [TBL] [Abstract][Full Text] [Related]
8. In-111 octreotide imaging in staging of small cell lung cancer. Hochstenbag MM; Heidendal GA; Wouters EF; ten Velde GP Clin Nucl Med; 1997 Dec; 22(12):811-6. PubMed ID: 9408640 [TBL] [Abstract][Full Text] [Related]
9. Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer. Soresi E; Invernizzi G; Boffi R; Possa M; Bombardieri E; Ciavarella GP; Liuzzi A Lung Cancer; 1997 Jul; 17(2-3):231-8. PubMed ID: 9237158 [TBL] [Abstract][Full Text] [Related]
12. 111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer. Crippa F; Bombardieri E; Chiti A; Soresi E; Boffi R; Buraggi GL J Nucl Biol Med (1991); 1994 Dec; 38(4):576-8. PubMed ID: 7786920 [TBL] [Abstract][Full Text] [Related]
13. The value of octreotide scintigraphy in patients with lung cancer. Kwekkeboom DJ; Kho GS; Lamberts SW; Reubi JC; Laissue JA; Krenning EP Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621 [TBL] [Abstract][Full Text] [Related]
14. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer. Leitha T; Meghdadi S; Studnicka M; Wolzt M; Marosi C; Angelberger P; Neumann M; Schlick W; Kletter K; Dudczak R J Nucl Med; 1993 Sep; 34(9):1397-402. PubMed ID: 8394882 [TBL] [Abstract][Full Text] [Related]
15. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model. Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Forssell-Aronsson E Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461 [TBL] [Abstract][Full Text] [Related]
16. Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results. Oliaro A; Filosso PL; Bello M; Casadio C; Angusti T; Masaneo I; Maggi G; Bisi G J Cardiovasc Surg (Torino); 1997 Jun; 38(3):313-5. PubMed ID: 9219485 [TBL] [Abstract][Full Text] [Related]